These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9858943)

  • 1. Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro.
    Knüpfer MM; Hernáiz-Driever P; Poppenborg H; Wolff JE; Cinatl J
    Anticancer Res; 1998; 18(5A):3585-9. PubMed ID: 9858943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro.
    Knüpfer MM; Pulzer F; Schindler I; Hernaíz Driever P; Knüpfer H; Keller E
    Anticancer Res; 2001; 21(1A):347-51. PubMed ID: 11299760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon gamma inhibits proliferation and hyaluronic acid adhesion of human malignant glioma cells in vitro.
    Knüpfer MM; Knüpfer H; Van Gool S; Domula M; Wolff JE
    Cytokine; 2000 Apr; 12(4):409-12. PubMed ID: 10805225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma inhibits proliferation and adhesion of T98G human malignant glioma cells in vitro.
    Knüpfer MM; Poppenborg H; Van Gool S; Domula M; Wolff JE
    Klin Padiatr; 1997; 209(4):271-4. PubMed ID: 9293461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid for the treatment of pediatric malignant glioma.
    Driever PH; Knüpfer MM; Cinatl J; Wolff JE
    Klin Padiatr; 1999; 211(4):323-8. PubMed ID: 10472571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors.
    Gilg AG; Tye SL; Tolliver LB; Wheeler WG; Visconti RP; Duncan JD; Kostova FV; Bolds LN; Toole BP; Maria BL
    Clin Cancer Res; 2008 Mar; 14(6):1804-13. PubMed ID: 18347183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression and hyaluronic acid binding of malignant glioma cells.
    Knüpfer MM; Poppenborg H; Hotfilder M; Kühnel K; Wolff JE; Domula M
    Clin Exp Metastasis; 1999 Feb; 17(1):71-6. PubMed ID: 10390150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression.
    Benítez JA; Arregui L; Cabrera G; Segovia J
    Neuroscience; 2008 Oct; 156(4):911-20. PubMed ID: 18771712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R; Krebs R; Baur R; Hombach V
    Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma inhibits growth and migration of A172 human glioblastoma cells.
    Knüpfer MM; Knüpfer H; Jendrossek V; Van Gool S; Wolff JE; Keller E
    Anticancer Res; 2001; 21(6A):3989-94. PubMed ID: 11911281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
    Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J
    Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
    Kanzawa T; Kondo Y; Ito H; Kondo S; Germano I
    Cancer Res; 2003 May; 63(9):2103-8. PubMed ID: 12727826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
    Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
    Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
    Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
    Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
    Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
    Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition and differentiation of C6 glioma cells on treatment with hmba.
    Shirsat NV; Kayal JJ; Shaikh S; Mehta A
    Cell Biol Int; 2001; 25(7):621-7. PubMed ID: 11448101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.
    Xia Q; Sung J; Chowdhury W; Chen CL; Höti N; Shabbeer S; Carducci M; Rodriguez R
    Cancer Res; 2006 Jul; 66(14):7237-44. PubMed ID: 16849572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.